{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:01:10Z","timestamp":1792684870693,"version":"4.5.0"},"reference-count":236,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023ZKZD44"],"award-info":[{"award-number":["2023ZKZD44"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-026-00979-9","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T03:56:30Z","timestamp":1782618990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatocellular carcinoma metastasis\u2013immune microenvironment crosstalk: emerging mechanisms and immunotherapy"],"prefix":"10.1186","volume":"31","author":[{"given":"Wenlong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"issue":"3","key":"979_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et\u00a0al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"979_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337.","journal-title":"J Hepatol"},{"issue":"10360","key":"979_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"key":"979_CR4","unstructured":"Strategies of primary prevention of liver cancer in China: expert consensus (2018). Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53(1):36\u201344."},{"issue":"7938","key":"979_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, et\u00a0al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612(7938):141\u20137.","journal-title":"Nature"},{"issue":"9972","key":"979_CR6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","volume":"385","author":"C Allemani","year":"2015","unstructured":"Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et\u00a0al. Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977\u20131010.","journal-title":"Lancet"},{"issue":"24","key":"979_CR7","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, et\u00a0al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202\u201312.","journal-title":"Cancer Res"},{"issue":"8","key":"979_CR8","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1053\/j.gastro.2017.02.040","volume":"152","author":"M Serper","year":"2017","unstructured":"Serper M, Taddei TH, Mehta R, D\u2019Addeo K, Dai F, Aytaman A, et\u00a0al. Association of Provider Specialty and Multidisciplinary Care with Hepatocellular Carcinoma Treatment and Mortality. Gastroenterology. 2017;152(8):1954\u201364.","journal-title":"Gastroenterology"},{"issue":"5","key":"979_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2019.12.014","volume":"72","author":"LQ Dong","year":"2020","unstructured":"Dong LQ, Peng LH, Ma LJ, Liu DB, Zhang S, Luo SZ, et\u00a0al. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. J Hepatol. 2020;72(5):896\u2013908.","journal-title":"J Hepatol"},{"issue":"3","key":"979_CR10","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/HEP.0000000000001191","volume":"82","author":"Y Yang","year":"2025","unstructured":"Yang Y, Ni Q, Li H, Sun J, Zhou X, Qu L, et\u00a0al. Genomic and the tumor microenvironment heterogeneity in multifocal hepatocellular carcinoma. Hepatology. 2025;82(3):582\u201398.","journal-title":"Hepatology"},{"issue":"7","key":"979_CR11","volume":"17","author":"N Salimiaghdam","year":"2025","unstructured":"Salimiaghdam N, Mustafa A, Pokuaa IO, Hamidi A, Chen E. Recurrent aggressive hepatocellular carcinoma presenting with chest wall metastasis and portal vein thrombosis: a rare case and a multidisciplinary perspective. Cureus. 2025;17(7):e87330.","journal-title":"Cureus"},{"issue":"1","key":"979_CR12","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1186\/s40001-025-03110-4","volume":"30","author":"J Fu","year":"2025","unstructured":"Fu J, Liu M, Chen S, Chen L, Liang S. Prognostic nomogram for hepatocellular carcinoma with major vascular invasion: a population-based study from the SEER database and a Chinese cohort. Eur J Med Res. 2025;30(1):836.","journal-title":"Eur J Med Res"},{"key":"979_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156211","volume":"275","author":"Y Wang","year":"2025","unstructured":"Wang Y, Tao L, Lv Q, Wang S, Jiang Q, He Y. Mechanisms of C5ORF13 in promoting epithelial-mesenchymal transition in hepatocellular carcinoma via eIF6 and the intervention of valproic acid. Pathol Res Pract. 2025;275:156211.","journal-title":"Pathol Res Pract"},{"key":"979_CR14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/ITT.S542811","volume":"14","author":"S Chen","year":"2025","unstructured":"Chen S, Wang N, Xiao Y, Jiang X, Shi F, Cai H, et\u00a0al. Efficiency and safety of HAIC combined with lenvatinib and PD-1 inhibitor for advanced hepatocellular carcinoma with lung metastasis: a multicenter propensity score matching analysis. Immunotargets Ther. 2025;14:953\u201365.","journal-title":"Immunotargets Ther"},{"issue":"9","key":"979_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjaf679","volume":"2025","author":"M Matsuda","year":"2025","unstructured":"Matsuda M, Yoshiya S, Kawada I, Nakamura S, Tada K, Ito K, et\u00a0al. Small intestinal metastasis of hepatocellular carcinoma diagnosed and resected as intestinal obstruction caused by a foreign body. J Surg Case Rep. 2025;2025(9):rjaf679.","journal-title":"J Surg Case Rep"},{"issue":"3","key":"979_CR16","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.18632\/oncotarget.6558","volume":"7","author":"JY Shi","year":"2016","unstructured":"Shi JY, Xing Q, Duan M, Wang ZC, Yang LX, Zhao YJ, et\u00a0al. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity. Oncotarget. 2016;7(3):2867\u201377.","journal-title":"Oncotarget"},{"issue":"1","key":"979_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/s12967-025-06592-2","volume":"23","author":"J Zhao","year":"2025","unstructured":"Zhao J, Li Y, Zhu J, Li H, Jin X. Ubiquitination in hepatocellular carcinoma immunity. J Transl Med. 2025;23(1):574.","journal-title":"J Transl Med"},{"issue":"6","key":"979_CR18","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.3390\/curroncol30060439","volume":"30","author":"SM Ruff","year":"2023","unstructured":"Ruff SM, Manne A, Cloyd JM, Dillhoff M, Ejaz A, Pawlik TM. Current landscape of immune checkpoint inhibitor therapy for hepatocellular carcinoma. Curr Oncol. 2023;30(6):5863\u201375.","journal-title":"Curr Oncol"},{"issue":"7","key":"979_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.it.2024.05.008","volume":"45","author":"AY Yang","year":"2024","unstructured":"Yang AY, Wistuba-Hamprecht K, Greten TF, Ruf B. Innate-like T cells in liver disease. Trends Immunol. 2024;45(7):535\u201348.","journal-title":"Trends Immunol"},{"key":"979_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.931995","volume":"12","author":"Y Lu","year":"2022","unstructured":"Lu Y, Ma S, Ding W, Sun P, Zhou Q, Duan Y, et\u00a0al. Resident immune cells of the liver in the tumor microenvironment. Front Oncol. 2022;12:931995.","journal-title":"Front Oncol"},{"key":"979_CR21","doi-asserted-by":"publisher","first-page":"1114605","DOI":"10.3389\/fimmu.2023.1114605","volume":"14","author":"M Papanastasatou","year":"2023","unstructured":"Papanastasatou M, Verykokakis M. Innate-like T lymphocytes in chronic liver disease. Front Immunol. 2023;14:1114605.","journal-title":"Front Immunol"},{"key":"979_CR22","doi-asserted-by":"publisher","first-page":"1506526","DOI":"10.3389\/fimmu.2025.1506526","volume":"16","author":"H Zheng","year":"2025","unstructured":"Zheng H, Xu B, Fan Y, Tuekprakhon A, Stamataki Z, Wang F. The role of immune regulation in HBV infection and hepatocellular carcinogenesis. Front Immunol. 2025;16:1506526.","journal-title":"Front Immunol"},{"issue":"1","key":"979_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12964-023-01266-2","volume":"21","author":"MH Razizadeh","year":"2023","unstructured":"Razizadeh MH, Zafarani A, Taghavi-Farahabadi M, Khorramdelazad H, Minaeian S, Mahmoudi M. Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we? Cell Commun Signal. 2023;21(1):261.","journal-title":"Cell Commun Signal"},{"key":"979_CR24","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","volume":"10","author":"M Zheng","year":"2019","unstructured":"Zheng M, Tian Z. Liver-mediated adaptive immune tolerance. Front Immunol. 2019;10:2525.","journal-title":"Front Immunol"},{"issue":"10","key":"979_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/ni.2691","volume":"14","author":"CN Jenne","year":"2013","unstructured":"Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol. 2013;14(10):996\u20131006.","journal-title":"Nat Immunol"},{"issue":"7","key":"979_CR26","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.4049\/jimmunol.1500839","volume":"195","author":"M Li","year":"2015","unstructured":"Li M, Sun R, Xu L, Yin W, Chen Y, Zheng X, et\u00a0al. Kupffer cells support hepatitis B virus-mediated CD8+ T cell exhaustion via hepatitis B core antigen-TLR2 interactions in mice. J Immunol. 2015;195(7):3100\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"979_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12072-025-10838-y","volume":"19","author":"A Lin","year":"2025","unstructured":"Lin A, Xiong M, Tang B, Jiang A, Shen J, Liu Z, et\u00a0al. Decoding the hepatic fibrosis-hepatocellular carcinoma axis: from mechanisms to therapeutic opportunities. Hepatol Int. 2025;19(4):732\u201359.","journal-title":"Hepatol Int"},{"key":"979_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.994480","volume":"13","author":"M Flores Molina","year":"2022","unstructured":"Flores Molina M, Abdelnabi MN, Mazouz S, Villafranca-Baughman D, Trinh VQ, Muhammad S, et\u00a0al. Distinct spatial distribution and roles of Kupffer cells and monocyte-derived macrophages in mouse acute liver injury. Front Immunol. 2022;13:994480.","journal-title":"Front Immunol"},{"issue":"1","key":"979_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","volume":"14","author":"T Fu","year":"2021","unstructured":"Fu T, Dai LJ, Wu SY, Xiao Y, Ma D, Jiang YZ, et\u00a0al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol. 2021;14(1):98.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"979_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo DZ, Zhang X, Zhang SQ, Zhang SY, Zhang XY, Yan JY, et\u00a0al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol Cancer. 2024;23(1):157.","journal-title":"Mol Cancer"},{"key":"979_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215834","volume":"545","author":"K Chen","year":"2022","unstructured":"Chen K, Wang Y, Hou Y, Wang Q, Long D, Liu X, et\u00a0al. Single cell RNA-seq reveals the CCL5\/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer. Cancer Lett. 2022;545:215834.","journal-title":"Cancer Lett"},{"issue":"4","key":"979_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41423-020-00565-9","volume":"18","author":"ST Paijens","year":"2021","unstructured":"Paijens ST, Vledder A, de Bruyn M, Nijman HW. Tumor-infiltrating lymphocytes in the immunotherapy era. Cell Mol Immunol. 2021;18(4):842\u201359.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"979_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13046-025-03490-9","volume":"44","author":"F Liu","year":"2025","unstructured":"Liu F, Li X, Zhang Y, Ge S, Shi Z, Liu Q, et\u00a0al. Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma. J Exp Clin Cancer Res. 2025;44(1):227.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"979_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jhep.2016.09.021","volume":"66","author":"M Furuta","year":"2017","unstructured":"Furuta M, Ueno M, Fujimoto A, Hayami S, Yasukawa S, Kojima F, et\u00a0al. Whole genome sequencing discriminates hepatocellular carcinoma with intrahepatic metastasis from multi-centric tumors. J Hepatol. 2017;66(2):363\u201373.","journal-title":"J Hepatol"},{"issue":"1","key":"979_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2014.6-c1","volume":"12","author":"Q Gao","year":"2015","unstructured":"Gao Q, Wang XY, Zhou J, Fan J. Multiple carcinogenesis contributes to the heterogeneity of HCC. Nat Rev Gastroenterol Hepatol. 2015;12(1):13.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"979_CR36","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/annonc\/mdz103","volume":"30","author":"LX Xu","year":"2019","unstructured":"Xu LX, He MH, Dai ZH, Yu J, Wang JG, Li XC, et\u00a0al. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma. Ann Oncol. 2019;30(6):990\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"979_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41392-023-01446-z","volume":"8","author":"YH Ling","year":"2023","unstructured":"Ling YH, Liu MN, Yin YX, Zhou ZG, Chen JW, Wei W, et\u00a0al. Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma. Signal Transduct Target Ther. 2023;8(1):244.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"979_CR38","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/2159-8290.CD-24-1259","volume":"15","author":"Y Lu","year":"2025","unstructured":"Lu Y, Xu L, Chen W, Liu W, Zhang Y, Zhou Q, et\u00a0al. Intrahepatic microbial heterogeneity in multifocal hepatocellular carcinoma and its association with host genomic and transcriptomic alterations. Cancer Discov. 2025;15(8):1630\u201348.","journal-title":"Cancer Discov"},{"issue":"8","key":"979_CR39","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1158\/2159-8290.CD-25-0899","volume":"15","author":"AK Dzutsev","year":"2025","unstructured":"Dzutsev AK, Trinchieri G. A new dimension in tumor heterogeneity: intratumoral bacteria impact multifocal hepatocellular carcinoma development. Cancer Discov. 2025;15(8):1540\u20132.","journal-title":"Cancer Discov"},{"issue":"9","key":"979_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21(9):541\u201357.","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"979_CR41","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.neuron.2025.07.009","volume":"113","author":"EK Sloan","year":"2025","unstructured":"Sloan EK, Chang A. Wired to spread: neural regulation of metastasis. Neuron. 2025;113(17):2726\u20138.","journal-title":"Neuron"},{"key":"979_CR42","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052449","author":"NM Eskow","year":"2025","unstructured":"Eskow NM, Hernando E. Modeling metastasis - Leveraging novel tools to streamline discovery in advanced cancer. Dis Model Mech. 2025. https:\/\/doi.org\/10.1242\/dmm.052449.","journal-title":"Dis Model Mech"},{"key":"979_CR43","doi-asserted-by":"publisher","first-page":"0144","DOI":"10.34133\/bmef.0144","volume":"6","author":"R Naserkhaki","year":"2025","unstructured":"Naserkhaki R, Shokouhian B, Tahamtani Y, Khosravi A, Iravani S, Zarrabi A, et\u00a0al. Revisiting treatment strategies: addressing epithelial-to-mesenchymal transition-induced resistance in hepatocellular carcinoma. BME Front. 2025;6:0144.","journal-title":"BME Front"},{"issue":"1","key":"979_CR44","doi-asserted-by":"publisher","first-page":"2321768","DOI":"10.1080\/15384047.2024.2321768","volume":"25","author":"Q Niu","year":"2024","unstructured":"Niu Q, Ye S, Zhao L, Qian Y, Liu F. The role of liver cancer stem cells in hepatocellular carcinoma metastasis. Cancer Biol Ther. 2024;25(1):2321768.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"979_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115592","volume":"44","author":"C Bresesti","year":"2025","unstructured":"Bresesti C, Carito E, Notaro M, Giacca G, Breggion S, Kerzel T, et\u00a0al. Reprogramming liver metastasis-associated macrophages toward an anti-tumoral phenotype through enforced miR-342 expression. Cell Rep. 2025;44(5):115592.","journal-title":"Cell Rep"},{"key":"979_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216680","volume":"587","author":"X Gao","year":"2024","unstructured":"Gao X, Pang C, Fan Z, Wang Y, Duan Y, Zhan H. Regulation of newly identified lysine lactylation in cancer. Cancer Lett. 2024;587:216680.","journal-title":"Cancer Lett"},{"key":"979_CR47","doi-asserted-by":"publisher","first-page":"1658795","DOI":"10.3389\/fimmu.2025.1658795","volume":"16","author":"W Xia","year":"2025","unstructured":"Xia W, Zhang X, Wang Y, Huang Z, Guo X, Fang L. Progress in targeting tumor-associated macrophages in cancer immunotherapy. Front Immunol. 2025;16:1658795.","journal-title":"Front Immunol"},{"key":"979_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.019","volume":"458","author":"Z Li","year":"2019","unstructured":"Li Z, Wu T, Zheng B, Chen L. Individualized precision treatment: targeting TAM in HCC. Cancer Lett. 2019;458:86\u201391.","journal-title":"Cancer Lett"},{"issue":"1","key":"979_CR49","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1186\/s12967-025-07376-4","volume":"23","author":"W Wang","year":"2025","unstructured":"Wang W, Yi Z, Yang Z, Huang Y, Chen H, Li Y, et\u00a0al. The hepatic macrophage: a key regulator of liver metastatic tumor microenvironment through cell crosstalk. J Transl Med. 2025;23(1):1334.","journal-title":"J Transl Med"},{"issue":"1","key":"979_CR50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.7150\/ijbs.97109","volume":"21","author":"T Li","year":"2025","unstructured":"Li T, Song X, Chen J, Li Y, Lin J, Li P, et\u00a0al. Kupffer cell-derived IL6 promotes hepatocellular carcinoma metastasis via the JAK1-ACAP4 pathway. Int J Biol Sci. 2025;21(1):285\u2013305.","journal-title":"Int J Biol Sci"},{"issue":"39","key":"979_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504929","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen C, Zhang Q, Li J, Zhou X, Gao D, Li L, et\u00a0al. Viral-directed augmentation of kupffer cell cross-presentation provokes antitumor immunity against liver metastasis. Adv Sci (Weinh). 2025;12(39):e04929.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"979_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41421-025-00819-8","volume":"11","author":"P Tian","year":"2025","unstructured":"Tian P, Wu Q, He D, Zhao W, Luo L, Jia Z, et\u00a0al. Breast cancer induces CD62L(+) Kupffer cells via DMBT1 to promote neutrophil extracellular trap formation and liver metastasis. Cell Discov. 2025;11(1):68.","journal-title":"Cell Discov"},{"key":"979_CR53","doi-asserted-by":"publisher","first-page":"1633315","DOI":"10.3389\/fimmu.2025.1633315","volume":"16","author":"D Liu","year":"2025","unstructured":"Liu D, Li M, Liang Y, Xu F, Li R, Sun Y. Immune microenvironment regulation and clinical immunotherapy strategies of metastatic liver cancer. Front Immunol. 2025;16:1633315.","journal-title":"Front Immunol"},{"issue":"1","key":"979_CR54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12964-022-00872-w","volume":"21","author":"Y Lu","year":"2023","unstructured":"Lu Y, Han G, Zhang Y, Zhang L, Li Z, Wang Q, et\u00a0al. M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma. Cell Commun Signal. 2023;21(1):299.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"979_CR55","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","volume":"352","author":"QM Fan","year":"2014","unstructured":"Fan QM, Jing YY, Yu GF, Kou XR, Ye F, Gao L, et\u00a0al. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 2014;352(2):160\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"979_CR56","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/s41467-025-62132-y","volume":"16","author":"T Chu","year":"2025","unstructured":"Chu T, Zhu G, Tang Z, Qu W, Yang R, Pan H, et\u00a0al. Metabolism archetype cancer cells induce protumor TREM2(+) macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma. Nat Commun. 2025;16(1):6770.","journal-title":"Nat Commun"},{"key":"979_CR57","doi-asserted-by":"publisher","first-page":"1606195","DOI":"10.3389\/fonc.2025.1606195","volume":"15","author":"WX Xu","year":"2025","unstructured":"Xu WX, Ye YM, Chen JL, Guo XY, Li C, Luo J, et\u00a0al. SPP1+ tumor-associated macrophages define a high-risk subgroup and inform personalized therapy in hepatocellular carcinoma. Front Oncol. 2025;15:1606195.","journal-title":"Front Oncol"},{"issue":"6","key":"979_CR58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00432-024-05831-1","volume":"150","author":"S Huang","year":"2024","unstructured":"Huang S, He L, Zhao Y, Wei Y, Wang Q, Gao Y, et\u00a0al. TREM1(+) tumor-associated macrophages secrete CCL7 to promote hepatocellular carcinoma metastasis. J Cancer Res Clin Oncol. 2024;150(6):320.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"979_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-02121-7","volume":"10","author":"M Yadav","year":"2025","unstructured":"Yadav M, Sharma A, Patne K, Tabasum S, Suryavanshi J, Rawat L, et\u00a0al. AXL signaling in cancer: from molecular insights to targeted therapies. Signal Transduct Target Ther. 2025;10(1):37.","journal-title":"Signal Transduct Target Ther"},{"key":"979_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122899","author":"K Arvanitakis","year":"2021","unstructured":"Arvanitakis K, Mitroulis I, Germanidis G. Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13122899.","journal-title":"Cancers (Basel)"},{"key":"979_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2024.11.009","volume":"177","author":"G Fan","year":"2025","unstructured":"Fan G, Na J, Shen Z, Lin F, Zhong L. Heterogeneity of tumor-associated neutrophils in hepatocellular carcinoma. Mol Immunol. 2025;177:1\u201316.","journal-title":"Mol Immunol"},{"issue":"5","key":"979_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188762","volume":"1877","author":"H Que","year":"2022","unstructured":"Que H, Fu Q, Lan T, Tian X, Wei X. Tumor-associated neutrophils and neutrophil-targeted cancer therapies. Biochim Biophys Acta Rev Cancer. 2022;1877(5):188762.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"979_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70368","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang K, Li J, Wang C, Li P, Du L. Neutrophil extracellular traps in cancer: from mechanisms to treatments. Clin Transl Med. 2025;15(6):e70368.","journal-title":"Clin Transl Med"},{"issue":"1","key":"979_CR64","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/ar.25673","volume":"309","author":"KM Mak","year":"2026","unstructured":"Mak KM, Shekhar AC, Ding SY. Neutrophil extracellular traps mediate pathophysiology of hepatic cells during liver injury. Anat Rec (Hoboken). 2026;309(1):214\u201334.","journal-title":"Anat Rec (Hoboken)"},{"issue":"4","key":"979_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1386","volume":"11","author":"N Li","year":"2022","unstructured":"Li N, Zheng X, Chen M, Huang L, Chen L, Huo R, et\u00a0al. Deficient DNASE1L3 facilitates neutrophil extracellular traps-induced invasion via cyclic GMP-AMP synthase and the non-canonical NF-\u03baB pathway in diabetic hepatocellular carcinoma. Clinical & Translational Immunology. 2022;11(4):e1386.","journal-title":"Clinical & Translational Immunology"},{"issue":"1","key":"979_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13045-019-0836-0","volume":"13","author":"LY Yang","year":"2020","unstructured":"Yang LY, Luo Q, Lu L, Zhu WW, Sun HT, Wei R, et\u00a0al. Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J Hematol Oncol. 2020;13(1):3.","journal-title":"J Hematol Oncol"},{"key":"979_CR67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/JHC.S303588","volume":"8","author":"X Guan","year":"2021","unstructured":"Guan X, Lu Y, Zhu H, Yu S, Zhao W, Chi X, et\u00a0al. The crosstalk between cancer cells and neutrophils enhances hepatocellular carcinoma metastasis via neutrophil extracellular traps-associated cathepsin G component: a potential therapeutic target. J Hepatocell Carcinoma. 2021;8:451\u201365.","journal-title":"J Hepatocell Carcinoma"},{"issue":"2","key":"979_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cac2.12388","volume":"43","author":"X Zhan","year":"2023","unstructured":"Zhan X, Wu R, Kong XH, You Y, He K, Sun XY, et\u00a0al. Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4\/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma. Cancer Commun (Lond). 2023;43(2):225\u201345.","journal-title":"Cancer Commun (Lond)"},{"key":"979_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216903","volume":"592","author":"JJ Pan","year":"2024","unstructured":"Pan JJ, Xie SZ, Zheng X, Xu JF, Xu H, Yin RQ, et\u00a0al. Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils. Cancer Lett. 2024;592:216903.","journal-title":"Cancer Lett"},{"issue":"1","key":"979_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cac2.12613","volume":"45","author":"J Yao","year":"2025","unstructured":"Yao J, Ji L, Wang G, Ding J. Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms. Cancer Commun. 2025;45(1):15\u201342.","journal-title":"Cancer Commun"},{"key":"979_CR71","first-page":"33","volume":"8","author":"MS Franz\u00e8","year":"2025","unstructured":"Franz\u00e8 MS, Saffioti F, Mavroeidis VK. Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC. Cancer Drug Resistance. 2025;8:33.","journal-title":"Cancer Drug Resistance"},{"issue":"1","key":"979_CR72","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et\u00a0al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6(1):362.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"979_CR73","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/jrr\/rraf035","volume":"66","author":"J Chen","year":"2025","unstructured":"Chen J, Lin Q, Lan R, Wu J, Wang Z, Chen R, et\u00a0al. A CCR5 antagonist enhances the radiosensitivity of hepatocarcinoma in a mouse model. J Radiat Res. 2025;66(4):396\u2013407.","journal-title":"J Radiat Res"},{"issue":"6","key":"979_CR74","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41419-021-03853-y","volume":"12","author":"S Xia","year":"2021","unstructured":"Xia S, Wu J, Zhou W, Zhang M, Zhao K, Liu J, et\u00a0al. SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells. Cell Death Dis. 2021;12(6):570.","journal-title":"Cell Death Dis"},{"key":"979_CR75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.25259\/Cytojournal_27_2025","volume":"22","author":"Y Jing","year":"2025","unstructured":"Jing Y, Wu Y. Sex-determining region Y-box 4 promotes the progression of advanced hepatocellular carcinoma and enhances regulatory T-cell infiltration and immune suppression. Cytojournal. 2025;22:56.","journal-title":"Cytojournal"},{"issue":"7","key":"979_CR76","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gutjnl-2024-333944","volume":"74","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Huang W, Hu D, Jiang J, Zhang J, Wu Z, et\u00a0al. E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression. Gut. 2025;74(7):1137\u201349.","journal-title":"Gut"},{"issue":"1","key":"979_CR77","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12951-025-03538-0","volume":"23","author":"Z Guo","year":"2025","unstructured":"Guo Z, Huang Q, Cui Z, Yang C, Yang L. Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma. J Nanobiotechnol. 2025;23(1):469.","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"979_CR78","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.7150\/thno.57659","volume":"11","author":"Q He","year":"2021","unstructured":"He Q, Huang W, Liu D, Zhang T, Wang Y, Ji X, et\u00a0al. Homeobox B5 promotes metastasis and poor prognosis in hepatocellular carcinoma, via FGFR4 and CXCL1 upregulation. Theranostics. 2021;11(12):5759\u201377.","journal-title":"Theranostics"},{"issue":"1","key":"979_CR79","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41419-025-07779-7","volume":"16","author":"D Huang","year":"2025","unstructured":"Huang D, Xu M, Wang H, Zhao Y, Zhang Z, Yu M, et\u00a0al. SIRP\u03b1 blockade therapy potentiates immunotherapy by inhibiting PD-L1(+) myeloid cells in hepatocellular carcinoma. Cell Death Dis. 2025;16(1):451.","journal-title":"Cell Death Dis"},{"issue":"32","key":"979_CR80","doi-asserted-by":"publisher","first-page":"45382","DOI":"10.1021\/acsami.5c04278","volume":"17","author":"J Lan","year":"2025","unstructured":"Lan J, Chu X, Xie L, Li B, Song Y, Lei L, et\u00a0al. Biomimetic nanoparticles with dual targeting for hepatocellular carcinoma promote tumor immune system activation by enhancing extracellular ATP homeostasis. ACS Appl Mater Interfaces. 2025;17(32):45382\u201397.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"979_CR81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1615\/CritRevImmunol.2024052486","volume":"44","author":"T Nguyen","year":"2024","unstructured":"Nguyen T, Chen PC, Pham J, Kaur K, Raman SS, Jewett A, et\u00a0al. Current and future states of natural killer cell-based immunotherapy in hepatocellular carcinoma. Crit Rev Immunol. 2024;44(5):71\u201385.","journal-title":"Crit Rev Immunol"},{"key":"979_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.887186","volume":"13","author":"M Sajid","year":"2022","unstructured":"Sajid M, Liu L, Sun C. The dynamic role of NK cells in liver cancers: role in HCC and HBV associated HCC and Its therapeutic implications. Front Immunol. 2022;13:887186.","journal-title":"Front Immunol"},{"issue":"1","key":"979_CR83","first-page":"80","volume":"40","author":"X Zhu","year":"2024","unstructured":"Zhu X, Zhou Y, Zhu S. Research progress on immunotherapy based on NK cells for hepatocellular carcinoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40(1):80\u20138.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"979_CR84","doi-asserted-by":"publisher","first-page":"1502270","DOI":"10.3389\/fonc.2024.1502270","volume":"14","author":"Y Huang","year":"2024","unstructured":"Huang Y, Liao H, Luo J, Wei H, Li A, Lu Y, et\u00a0al. Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma. Front Oncol. 2024;14:1502270.","journal-title":"Front Oncol"},{"issue":"1","key":"979_CR85","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42003-025-07798-2","volume":"8","author":"J Geng","year":"2025","unstructured":"Geng J, Xie M, Yan M, Xie X, Wang F, Zhu R, et\u00a0al. Invariant NK T cells counteract HCC metastasis by mediating the migration of splenic CD4(+) T cells into the white pulp and infiltration of B cells. Commun Biol. 2025;8(1):351.","journal-title":"Commun Biol"},{"issue":"3","key":"979_CR86","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/HEP.0000000000000934","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Li T, Ding L, Wang J, Chen C, Liu T, et\u00a0al. Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. Hepatology. 2025;81(3):791\u2013807.","journal-title":"Hepatology"},{"issue":"1","key":"979_CR87","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1007\/s12672-025-03138-2","volume":"16","author":"S Tavakoli","year":"2025","unstructured":"Tavakoli S, Samareh-Salavati M, Rahnama MA, Abdolahi S, Hassanzadeh A, Ghazvinian Z, et\u00a0al. Natural killer cell therapy in hepatocellular carcinoma: a comprehensive review. Discover Oncology. 2025;16(1):1348.","journal-title":"Discover Oncology"},{"key":"979_CR88","doi-asserted-by":"crossref","unstructured":"Fridman WH, Petitprez F, Meylan M, Chen TW, Sun CM, Roumenina LT, et al. B cells and cancer: to B or not to B? J Exp Med. 2021;218(1).","DOI":"10.1084\/jem.20200851"},{"key":"979_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.647854","volume":"11","author":"M Qin","year":"2021","unstructured":"Qin M, Wang D, Fang Y, Zheng Z, Liu X, Wu F, et\u00a0al. Current perspectives on B lymphocytes in the immunobiology of hepatocellular carcinoma. Front Oncol. 2021;11:647854.","journal-title":"Front Oncol"},{"issue":"10","key":"979_CR90","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00262-009-0733-4","volume":"58","author":"M Reuschenbach","year":"2009","unstructured":"Reuschenbach M, von Knebel Doeberitz M, Wentzensen N. A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother. 2009;58(10):1535\u201344.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"979_CR91","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","volume":"66","author":"M Garnelo","year":"2017","unstructured":"Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, et\u00a0al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. 2017;66(2):342\u201351.","journal-title":"Gut"},{"key":"979_CR92","doi-asserted-by":"crossref","unstructured":"Wang H, Herman A, Barrow F, Abdel-Ghani A, Draxler M, Fredrickson G, et\u00a0al. Single-cell RNA sequencing reveals a reprogramming of hepatic immune cells and a protective role for B cells in MASH-driven HCC. Hepatol Commun. 2025;9(5).","DOI":"10.1097\/HC9.0000000000000668"},{"issue":"1","key":"979_CR93","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1186\/s12967-025-06869-6","volume":"23","author":"W Hou","year":"2025","unstructured":"Hou W, Jiang J, Zhu L, Xu H, Zhu L. Single-cell RNA sequencing reveals a B cell-related immunosuppressive landscape and a potential suppressor in hepatocellular carcinoma. J Transl Med. 2025;23(1):847.","journal-title":"J Transl Med"},{"issue":"10","key":"979_CR94","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","volume":"22","author":"D Seyhan","year":"2025","unstructured":"Seyhan D, Allaire M, Fu Y, Conti F, Wang XW, Gao B, et\u00a0al. Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy. Cell Mol Immunol. 2025;22(10):1132\u201358.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"979_CR95","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/cei.13094","volume":"192","author":"W Wang","year":"2018","unstructured":"Wang W, Wang Z, Qin Y, Tang G, Cai G, Liu Y, et\u00a0al. Th17, synchronically increased with T(regs) and B(regs), promoted by tumour cells via cell-contact in primary hepatic carcinoma. Clin Exp Immunol. 2018;192(2):181\u201392.","journal-title":"Clin Exp Immunol"},{"issue":"17","key":"979_CR96","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1097\/CM9.0000000000003544","volume":"138","author":"H Yu","year":"2025","unstructured":"Yu H, Shi M, Li X, Liang Z, Li K, Hu Y, et\u00a0al. Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion. Chin Med J (Engl). 2025;138(17):2148\u201358.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"979_CR97","doi-asserted-by":"publisher","first-page":"832","DOI":"10.62347\/ZIAX8828","volume":"14","author":"SL Lian","year":"2024","unstructured":"Lian SL, Lu YT, Lu YJ, Yao YL, Wang XL, Jiang RQ. Tumor-associated macrophages promoting PD-L1 expression in infiltrating B cells through the CXCL12\/CXCR4 axis in human hepatocellular carcinoma. Am J Cancer Res. 2024;14(2):832\u201353.","journal-title":"Am J Cancer Res"},{"key":"979_CR98","doi-asserted-by":"crossref","unstructured":"Liu X, Liu Z, Kobayashi T, Lei PJ, Shi Y, Yuan D, et\u00a0al. Inhibiting B-cell-mediated immunosuppression to enhance the immunotherapy efficacy in hepatocellular carcinoma. Res Sq. 2025.","DOI":"10.1101\/2025.03.04.641494"},{"issue":"1","key":"979_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40425-018-0451-6","volume":"6","author":"L Ye","year":"2018","unstructured":"Ye L, Zhang Q, Cheng Y, Chen X, Wang G, Shi M, et\u00a0al. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1(+) regulatory B cell expansion. J Immunother Cancer. 2018;6(1):145.","journal-title":"J Immunother Cancer"},{"issue":"12","key":"979_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101189","volume":"6","author":"N Petriv","year":"2024","unstructured":"Petriv N, Suo H, Hochnadel I, Timrott K, Bondarenko N, Neubert L, et\u00a0al. Essential roles of B cell subsets in the progression of MASLD and HCC. JHEP Rep. 2024;6(12):101189.","journal-title":"JHEP Rep"},{"issue":"1","key":"979_CR101","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13148-025-02000-0","volume":"17","author":"T Xia","year":"2025","unstructured":"Xia T, Hou Z, Wang S, Sun J, Yang H, Miao P, et\u00a0al. HMGA1 drives EMT in obliterative bronchiolitis through epigenetic regulation of chromatin accessibility in pulmonary epithelial cells. Clin Epigenetics. 2025;17(1):192.","journal-title":"Clin Epigenetics"},{"issue":"3","key":"979_CR102","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","volume":"4","author":"DE Speiser","year":"2023","unstructured":"Speiser DE, Chijioke O, Schaeuble K, M\u00fcnz C. CD4(+) T cells in cancer. Nat Cancer. 2023;4(3):317\u201329.","journal-title":"Nat Cancer"},{"issue":"2","key":"979_CR103","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","volume":"25","author":"J Crespo","year":"2013","unstructured":"Crespo J, Sun H, Welling TH, Tian Z, Zou W. T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Curr Opin Immunol. 2013;25(2):214\u201321.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"979_CR104","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","volume":"17","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shao Q, Peng G. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment. Cell Mol Immunol. 2020;17(1):27\u201335.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"979_CR105","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1731","volume":"14","author":"B Yue","year":"2024","unstructured":"Yue B, Gao Y, Hu Y, Zhan M, Wu Y, Lu L. Harnessing CD8(+) T cell dynamics in hepatitis B virus-associated liver diseases: insights, therapies and future directions. Clin Transl Med. 2024;14(7):e1731.","journal-title":"Clin Transl Med"},{"key":"979_CR106","doi-asserted-by":"crossref","unstructured":"Huang BY, Mi ZQ, Zhang XY, Ji YC, Wu MZ, Cheng ZF, et al. Vessels encapsulating tumor clusters promote non-invasive metastasis of hepatocellular carcinoma by shaping an immunosuppressive microenvironment. J Clin Invest. 2026.","DOI":"10.1172\/JCI193758"},{"key":"979_CR107","doi-asserted-by":"crossref","unstructured":"Ilyas SI, Wang J, El-Khoueiry AB. Liver Cancer Immunity. Hepatology. 2021;73(Suppl 1):86\u2013103.","DOI":"10.1002\/hep.31416"},{"issue":"10","key":"979_CR108","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1172\/JCI137553","volume":"130","author":"VW Yuen","year":"2020","unstructured":"Yuen VW, Wong CC. Hypoxia-inducible factors and innate immunity in liver cancer. J Clin Invest. 2020;130(10):5052\u201362.","journal-title":"J Clin Invest"},{"issue":"1","key":"979_CR109","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hep.30593","volume":"70","author":"Q Wu","year":"2019","unstructured":"Wu Q, Zhou W, Yin S, Zhou Y, Chen T, Qian J, et\u00a0al. Blocking triggering receptor expressed on myeloid cells-1-positive tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-programmed cell death ligand 1 resistance in liver cancer. Hepatology. 2019;70(1):198\u2013214.","journal-title":"Hepatology"},{"key":"979_CR110","doi-asserted-by":"crossref","unstructured":"Hao ZN, Tan XP, Zhang Q, Li J, Xia R, Ma Z. Lactate and lactylation: dual regulators of T-cell-mediated tumor immunity and immunotherapy. Biomolecules. 2024;14(12).","DOI":"10.3390\/biom14121646"},{"key":"979_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02240","volume":"10","author":"K Heim","year":"2019","unstructured":"Heim K, Neumann-Haefelin C, Thimme R, Hofmann M. Heterogeneity of HBV-specific CD8(+) T-cell failure: implications for immunotherapy. Front Immunol. 2019;10:2240.","journal-title":"Front Immunol"},{"issue":"8","key":"979_CR112","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/2159-8290.CD-24-1409","volume":"15","author":"SF Tzeng","year":"2025","unstructured":"Tzeng SF, Yu YR, Park J, von Renesse J, Hsiao HW, Hsu CH, et\u00a0al. PLT012, a humanized CD36-blocking antibody, is effective for unleashing antitumor immunity against liver cancer and liver metastasis. Cancer Discov. 2025;15(8):1676\u201396.","journal-title":"Cancer Discov"},{"issue":"21","key":"979_CR113","doi-asserted-by":"publisher","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","volume":"70","author":"R Bos","year":"2010","unstructured":"Bos R, Sherman LA. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. Cancer Res. 2010;70(21):8368\u201377.","journal-title":"Cancer Res"},{"issue":"13","key":"979_CR114","doi-asserted-by":"publisher","first-page":"2000224","DOI":"10.1002\/advs.202000224","volume":"7","author":"B Zheng","year":"2020","unstructured":"Zheng B, Wang D, Qiu X, Luo G, Wu T, Yang S, et\u00a0al. Trajectory and functional analysis of PD-1(high) CD4(+)CD8(+) T cells in hepatocellular carcinoma by single-cell cytometry and transcriptome sequencing. Adv Sci (Weinh). 2020;7(13):2000224.","journal-title":"Adv Sci (Weinh)"},{"key":"979_CR115","doi-asserted-by":"crossref","unstructured":"Chaoul N, Mancarella S, Lupo L, Giannelli G, Dituri F. Impaired anti-tumor T cell response in hepatocellular carcinoma. Cancers (Basel). 2020;12(3).","DOI":"10.3390\/cancers12030627"},{"key":"979_CR116","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.omtn.2020.07.008","volume":"21","author":"R Dhanasekaran","year":"2020","unstructured":"Dhanasekaran R, Park J, Yevtodiyenko A, Bellovin DI, Adam SJ, Kd AR, et\u00a0al. MYC ASO impedes tumorigenesis and elicits oncogene addiction in autochthonous transgenic mouse models of HCC and RCC. Mol Ther Nucleic Acids. 2020;21:850\u20139.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"10","key":"979_CR117","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s43018-023-00624-w","volume":"4","author":"C Zheng","year":"2023","unstructured":"Zheng C, Snow BE, Elia AJ, Nechanitzky R, Dominguez-Brauer C, Liu S, et\u00a0al. Tumor-specific cholinergic CD4(+) T lymphocytes guide immunosurveillance of hepatocellular carcinoma. Nat Cancer. 2023;4(10):1437\u201354.","journal-title":"Nat Cancer"},{"issue":"1","key":"979_CR118","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol Cancer. 2020;19(1):116.","journal-title":"Mol Cancer"},{"key":"979_CR119","doi-asserted-by":"publisher","first-page":"1431211","DOI":"10.3389\/fimmu.2024.1431211","volume":"15","author":"G Du","year":"2024","unstructured":"Du G, Dou C, Sun P, Wang S, Liu J, Ma L. Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy. Front Immunol. 2024;15:1431211.","journal-title":"Front Immunol"},{"issue":"20","key":"979_CR120","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1182\/blood-2018-11-844548","volume":"133","author":"MA Giese","year":"2019","unstructured":"Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019;133(20):2159\u201367.","journal-title":"Blood"},{"issue":"8","key":"979_CR121","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.4049\/jimmunol.175.8.5541","volume":"175","author":"S Dasgupta","year":"2005","unstructured":"Dasgupta S, Bhattacharya-Chatterjee M, O\u2019Malley BW Jr, Chatterjee SK. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer. J Immunol. 2005;175(8):5541\u201350.","journal-title":"J Immunol"},{"issue":"2","key":"979_CR122","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4254\/wjh.v7.i2.165","volume":"7","author":"F Heindryckx","year":"2015","unstructured":"Heindryckx F, Gerwins P. Targeting the tumor stroma in hepatocellular carcinoma. World J Hepatol. 2015;7(2):165\u201376.","journal-title":"World J Hepatol"},{"issue":"6","key":"979_CR123","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1002\/hep.32062","volume":"74","author":"Q He","year":"2021","unstructured":"He Q, Liu M, Huang W, Chen X, Zhang B, Zhang T, et\u00a0al. IL-1\u03b2-induced elevation of solute carrier family 7 member 11 promotes hepatocellular carcinoma metastasis through up-regulating programmed death ligand 1 and colony-stimulating factor 1. Hepatology. 2021;74(6):3174\u201393.","journal-title":"Hepatology"},{"issue":"1","key":"979_CR124","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40164-024-00476-9","volume":"13","author":"XT Shen","year":"2024","unstructured":"Shen XT, Xie SZ, Zheng X, Zou TT, Hu BY, Xu J, et\u00a0al. Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma. Exp Hematol Oncol. 2024;13(1):20.","journal-title":"Exp Hematol Oncol"},{"key":"979_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.650486","volume":"12","author":"I Lurje","year":"2021","unstructured":"Lurje I, Werner W, Mohr R, Roderburg C, Tacke F, Hammerich L. In situ vaccination as a strategy to modulate the immune microenvironment of hepatocellular carcinoma. Front Immunol. 2021;12:650486.","journal-title":"Front Immunol"},{"key":"979_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156228","volume":"275","author":"D Pan","year":"2025","unstructured":"Pan D, Zhang H, Zhou J, He S, Yuan G. METTL3\/IGF2BP2 stabilizes IQGAP3 via m6A modification to drive HCC metastasis through TGF-\u03b2\/Smad signaling and EMT. Pathol Res Pract. 2025;275:156228.","journal-title":"Pathol Res Pract"},{"key":"979_CR127","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12935-018-0590-3","volume":"18","author":"L Li","year":"2018","unstructured":"Li L, Sun P, Zhang C, Li Z, Cui K, Zhou W. MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma. Cancer Cell Int. 2018;18:95.","journal-title":"Cancer Cell Int"},{"key":"979_CR128","doi-asserted-by":"crossref","unstructured":"Xiao L, Cao L, Luo Z, Zheng S, Huang D. TGF-\u03b2 induces a decrease in CAPZA1 expression to promote the invasiveness of hepatocellular carcinoma cells. Am J Med Sci. 2025.","DOI":"10.1016\/j.amjms.2025.07.013"},{"issue":"1","key":"979_CR129","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12935-025-03803-0","volume":"25","author":"H Shen","year":"2025","unstructured":"Shen H, Li H, Tang H. CCDC110 promotes the progression of hepatocellular carcinoma by activating the TGF-\u03b2\/SMAD signaling pathway through targeted regulation of TGFBR1. Cancer Cell Int. 2025;25(1):183.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"979_CR130","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-025-01125-5","volume":"31","author":"Q Yin","year":"2025","unstructured":"Yin Q, Yao Y, Ni J, Zhang Y, Wu J, Zeng H, et\u00a0al. DLAT activates EMT to promote HCC metastasis by regulating GLUT1-mediated aerobic glycolysis. Mol Med. 2025;31(1):71.","journal-title":"Mol Med"},{"issue":"2","key":"979_CR131","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s10528-024-10897-0","volume":"63","author":"MJ Saadh","year":"2025","unstructured":"Saadh MJ, Hussain QM, Alazzawi TS, Fahdil AA, Athab ZH, Yarmukhamedov B, et\u00a0al. MicroRNA as key players in hepatocellular carcinoma: insights into their role in metastasis. Biochem Genet. 2025;63(2):1014\u201362.","journal-title":"Biochem Genet"},{"key":"979_CR132","doi-asserted-by":"crossref","unstructured":"Yang Y, Wang J, Wu Q, Wang Y, Meng H, Zeng L, et al. HDAC11 interacts with the NuRD (MTA3) complex to transcriptionally suppress TGF\u03b21 expression and inhibit hepatocellular carcinoma metastasis. Clin Epigenetics. 2026.","DOI":"10.1186\/s13148-026-02050-y"},{"key":"979_CR133","doi-asserted-by":"crossref","unstructured":"Sun Y, Weng X, Chen W, Ge J, Ding B, Ru J, et al. MYBBP1A\u2011mediated IGFBP4 promoter methylation promotes epithelial\u2011mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer. Int J Oncol. 2025;66(1).","DOI":"10.3892\/ijo.2024.5710"},{"key":"979_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101239","volume":"70","author":"X Lin","year":"2025","unstructured":"Lin X, Xu Y, Bai E, Deng Y, Zhang W, Xue R, et\u00a0al. 6-aminonicotinamide, a G6PD inhibitor, mitigates CAPS1 reduction mediated HCC metastasis via ERK and GSK3\u03b2 signals. Neoplasia. 2025;70:101239.","journal-title":"Neoplasia"},{"issue":"5","key":"979_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31237","volume":"239","author":"J Liang","year":"2024","unstructured":"Liang J, Yao N, Deng B, Li J, Jiang Y, Liu T, et\u00a0al. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via \u03b2-catenin signaling in hepatocellular carcinoma. J Cell Physiol. 2024;239(5):e31237.","journal-title":"J Cell Physiol"},{"issue":"11","key":"979_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101380","volume":"15","author":"Z Gong","year":"2025","unstructured":"Gong Z, Li Y, Nie Y, Zhang S, Tang X, Hu Y, et\u00a0al. USP50-mediated NLRP3 deubiquitination enhances NLRP3 inflammasome activation to suppress HCC metastasis. J Pharm Anal. 2025;15(11):101380.","journal-title":"J Pharm Anal"},{"issue":"2","key":"979_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202404083","volume":"12","author":"H Han","year":"2025","unstructured":"Han H, Zhang C, Shi W, Wang J, Zhao W, Du Y, et\u00a0al. NSUN5 facilitates hepatocellular carcinoma progression by increasing SMAD3 expression. Adv Sci (Weinh). 2025;12(2):e2404083.","journal-title":"Adv Sci (Weinh)"},{"key":"979_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, et\u00a0al. Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and challenges. Pharmacol Res. 2023;187:106553.","journal-title":"Pharmacol Res"},{"issue":"1","key":"979_CR139","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12885-024-12364-w","volume":"24","author":"Y Du","year":"2024","unstructured":"Du Y, Xu Y, Guo X, Tan C, Zhu X, Liu G, et\u00a0al. Methylation-regulated tumor suppressor gene PDE7B promotes HCC invasion and metastasis through the PI3K\/AKT signaling pathway. BMC Cancer. 2024;24(1):624.","journal-title":"BMC Cancer"},{"issue":"4","key":"979_CR140","volume":"17","author":"RP Chaulagain","year":"2025","unstructured":"Chaulagain RP, Padder AM, Shrestha H, Gupta R, Bhandari R, Shrestha Y, et\u00a0al. Deciphering the Matrisome: extracellular matrix remodeling in liver cirrhosis and hepatocellular carcinoma. Cureus. 2025;17(4):e82171.","journal-title":"Cureus"},{"issue":"1","key":"979_CR141","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12072-023-10615-9","volume":"18","author":"CL Yang","year":"2024","unstructured":"Yang CL, Song R, Hu JW, Huang JT, Li NN, Ni HH, et\u00a0al. Integrating single-cell and bulk RNA sequencing reveals CK19 + cancer stem cells and their specific SPP1 + tumor-associated macrophage niche in HBV-related hepatocellular carcinoma. Hepatol Int. 2024;18(1):73\u201390.","journal-title":"Hepatol Int"},{"key":"979_CR142","doi-asserted-by":"crossref","unstructured":"Chen J, Xu W, Chen Y, Xie X, Zhang Y, Ma C, et\u00a0al. Matrix Metalloproteinase 9 Facilitates Hepatitis B Virus Replication through Binding with Type I Interferon (IFN) Receptor 1 To Repress IFN\/JAK\/STAT Signaling. J Virol. 2017;91(8).","DOI":"10.1128\/JVI.01824-16"},{"issue":"6","key":"979_CR143","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/gutjnl-2023-331342","volume":"73","author":"N Cai","year":"2024","unstructured":"Cai N, Cheng K, Ma Y, Liu S, Tao R, Li Y, et\u00a0al. Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8(+) T cell-mediated antitumour immunity and improves anti-PD-1 efficacy. Gut. 2024;73(6):985\u201399.","journal-title":"Gut"},{"issue":"7","key":"979_CR144","first-page":"2238","volume":"26","author":"ZY Guo","year":"2022","unstructured":"Guo ZY, Jiang LP. Matrix metalloproteinase 12 (MMP12) as an adverse prognostic biomarker of vascular invasion in hepatic cell carcinoma. Eur Rev Med Pharmacol Sci. 2022;26(7):2238\u201349.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"979_CR145","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/hyb.2006.25.60","volume":"25","author":"L Wang","year":"2006","unstructured":"Wang L, Ku XM, Li Y, Bian HJ, Zhang SH, Ye H, et\u00a0al. Regulation of matrix metalloproteinase production and tumor cell invasion by four monoclonal antibodies against different epitopes of HAb18G\/CD147 extracellular domain. Hybridoma (Larchmt). 2006;25(2):60\u20137.","journal-title":"Hybridoma (Larchmt)"},{"key":"979_CR146","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.canlet.2020.02.003","volume":"477","author":"Y Ge","year":"2020","unstructured":"Ge Y, Mu W, Ba Q, Li J, Jiang Y, Xia Q, et\u00a0al. Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application. Cancer Lett. 2020;477:41\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"979_CR147","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s40164-024-00571-x","volume":"13","author":"SZ Xie","year":"2024","unstructured":"Xie SZ, Yang LY, Wei R, Shen XT, Pan JJ, Yu SZ, et\u00a0al. Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis. Exp Hematol Oncol. 2024;13(1):111.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"979_CR148","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13046-023-02748-4","volume":"42","author":"C Zhang","year":"2023","unstructured":"Zhang C, Li Q, Xu Q, Dong W, Li C, Deng B, et\u00a0al. Pulmonary interleukin 1 beta\/serum amyloid A3 axis promotes lung metastasis of hepatocellular carcinoma by facilitating the pre-metastatic niche formation. J Exp Clin Cancer Res. 2023;42(1):166.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"979_CR149","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11684-022-0928-z","volume":"16","author":"Z Huang","year":"2022","unstructured":"Huang Z, Wen J, Wang Y, Han S, Li Z, Hu X, et\u00a0al. Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives. Front Med. 2022;16(4):551\u201373.","journal-title":"Front Med"},{"key":"979_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943866","volume":"12","author":"X Yuan","year":"2022","unstructured":"Yuan X, Zhuang M, Zhu X, Cheng D, Liu J, Sun D, et\u00a0al. Emerging perspectives of bone metastasis in hepatocellular carcinoma. Front Oncol. 2022;12:943866.","journal-title":"Front Oncol"},{"issue":"6","key":"979_CR151","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3892\/ol.2025.15322","volume":"30","author":"CH Hsieh","year":"2025","unstructured":"Hsieh CH, Chuang PC. Immune checkpoint biology in hepatocellular carcinoma (Review). Oncol Lett. 2025;30(6):576.","journal-title":"Oncol Lett"},{"issue":"21","key":"979_CR152","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1158\/0008-5472.CAN-24-3355","volume":"85","author":"YH Ruan","year":"2025","unstructured":"Ruan YH, Ning WR, Huang AQ, Jiang D, Zhu BX, Liu XC, et\u00a0al. Intracellular IL1\u03b1 in peritumoral monocytes induces IL8 production and inhibits mitophagy to promote stemness and metastasis of hepatocellular carcinoma. Cancer Res. 2025;85(21):4164\u201381.","journal-title":"Cancer Res"},{"issue":"2","key":"979_CR153","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2025.01.027","volume":"83","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Geng C, Song M, Liang H, Zhou K, Liu Y, et\u00a0al. Loss of SGK1 supports metastatic colonization in hepatocellular carcinoma by promoting resistance to T cell-mediated immunity. J Hepatol. 2025;83(2):397\u2013410.","journal-title":"J Hepatol"},{"key":"979_CR154","doi-asserted-by":"publisher","first-page":"394632024124944","DOI":"10.1177\/03946320241249445","volume":"38","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zheng L, Ma Y, Zhang Y, Yue C, Gu F, et\u00a0al. Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK\/JNK\/IL-8 pathway. Int J Immunopathol Pharmacol. 2024;38:3946320241249445.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"979_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108078","volume":"301","author":"J Jiao","year":"2025","unstructured":"Jiao J, Shao K, Liu Z, Liu L, Nie Z, Wu J, et\u00a0al. Epigenetic activation of JAG1 by AID contributes to metastasis of hepatocellular carcinoma. J Biol Chem. 2025;301(1):108078.","journal-title":"J Biol Chem"},{"key":"979_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1415435","volume":"15","author":"YZ Chen","year":"2024","unstructured":"Chen YZ, Meng ZS, Xiang ZL. HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis. Front Immunol. 2024;15:1415435.","journal-title":"Front Immunol"},{"issue":"4","key":"979_CR157","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/imm.13853","volume":"173","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wu T, Wang Y, Luo D, Zhao Z, Sun H, et\u00a0al. Hypoxic tumour-derived exosomal miR-1290 exacerbates the suppression of CD8+ T cells by promoting M2 macrophage polarization. Immunology. 2024;173(4):672\u201388.","journal-title":"Immunology"},{"issue":"11","key":"979_CR158","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s00262-012-1278-5","volume":"61","author":"TW Sun","year":"2012","unstructured":"Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, Yi Y, et\u00a0al. B7\u2013H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunol Immunother. 2012;61(11):2171\u201382.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"979_CR159","first-page":"B7","volume":"12","author":"IA Koumprentziotis","year":"2024","unstructured":"Koumprentziotis IA, Theocharopoulos C, Foteinou D, Angeli E, Anastasopoulou A, Gogas H, et\u00a0al. New emerging targets in cancer immunotherapy: the role of B7-H3. Vaccines (Basel). 2024;12(1):B7\u2013B3.","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"979_CR160","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00281-025-01058-5","volume":"47","author":"Y Dai","year":"2025","unstructured":"Dai Y, Ye Z, Lin X, Zhang S. Immunopathological insights into endometriosis: from research advances to future treatments. Semin Immunopathol. 2025;47(1):31.","journal-title":"Semin Immunopathol"},{"issue":"3","key":"979_CR161","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/15321819.2022.2137810","volume":"44","author":"DO Helmy","year":"2023","unstructured":"Helmy DO, Khattab F, Hegazy AE, Sabry RM. Immunohistochemical expression of immune check point protein PDL-1 in hepatocellular carcinoma denotes its prognostic significance and association with survival. J Immunoassay Immunochem. 2023;44(3):213\u201328.","journal-title":"J Immunoassay Immunochem"},{"issue":"3","key":"979_CR162","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4254\/wjh.v16.i3.353","volume":"16","author":"T Gupta","year":"2024","unstructured":"Gupta T, Jarpula NS. Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status. World J Hepatol. 2024;16(3):353\u201365.","journal-title":"World J Hepatol"},{"key":"979_CR163","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/bs.acr.2022.03.002","volume":"156","author":"J Argemi","year":"2022","unstructured":"Argemi J, Ponz-Sarvise M, Sangro B. Immunotherapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: current and developing strategies. Adv Cancer Res. 2022;156:367\u2013413.","journal-title":"Adv Cancer Res"},{"key":"979_CR164","doi-asserted-by":"crossref","unstructured":"Giovannini C, Suzzi F, Tovoli F, Bruccoleri M, Marseglia M, Alimenti E, et al. Low-baseline PD1+ granulocytes predict responses to atezolizumab-bevacizumab in hepatocellular carcinoma. Cancers (Basel). 2023;15(6).","DOI":"10.3390\/cancers15061661"},{"key":"979_CR165","doi-asserted-by":"crossref","unstructured":"Dhyani A, Harding JJ. Immune checkpoint blockade and transarterial chemoembolization in liver-limited hepatocellular carcinoma: new questions at the dawn of a new era. J Immunother Cancer. 2025;13(8).","DOI":"10.1136\/jitc-2025-012658"},{"key":"979_CR166","doi-asserted-by":"publisher","first-page":"1533874","DOI":"10.3389\/fimmu.2025.1533874","volume":"16","author":"SA El-Kafrawy","year":"2025","unstructured":"El-Kafrawy SA, Elkafrawy MS, Azhar EI, Saeed A, Tabll AA. Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches. Front Immunol. 2025;16:1533874.","journal-title":"Front Immunol"},{"key":"979_CR167","doi-asserted-by":"publisher","first-page":"1598436","DOI":"10.3389\/fimmu.2025.1598436","volume":"16","author":"D Wu","year":"2025","unstructured":"Wu D, Fan Y, Zhang M, Wang X, He X, Guo X, et\u00a0al. Tumor-suppressing multi-enterobacteria and PD-1\/PD-L1 immune checkpoint inhibitor combination improves the outcome of hepatocellular carcinoma therapy. Front Immunol. 2025;16:1598436.","journal-title":"Front Immunol"},{"issue":"1","key":"979_CR168","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40364-025-00820-z","volume":"13","author":"Z Quan","year":"2025","unstructured":"Quan Z, Gao Y, Sun B, Guo Y, Jin Z, Hao N, et\u00a0al. Combination immunotherapy targeting LAG-3, PD-1 and STING suppresses hepatocellular carcinoma as monitored by LAG-3 targeted PET imaging. Biomark Res. 2025;13(1):102.","journal-title":"Biomark Res"},{"issue":"1","key":"979_CR169","doi-asserted-by":"publisher","first-page":"2516502","DOI":"10.1080\/02656736.2025.2516502","volume":"42","author":"N Wu","year":"2025","unstructured":"Wu N, Pei X, Cai W, Ye X, Lu W. Blocking Tim-3 enhances CD8(+) T cell activity to inhibit hepatocellular carcinoma recurrence post-radiofrequency ablation. Int J Hyperthermia. 2025;42(1):2516502.","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"979_CR170","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1038\/s41467-025-60757-7","volume":"16","author":"D Hsiehchen","year":"2025","unstructured":"Hsiehchen D, Kainthla R, Kline H, Siglinsky E, Ahn C, Zhu H. Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial. Nat Commun. 2025;16(1):5819.","journal-title":"Nat Commun"},{"issue":"4","key":"979_CR171","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000544163","volume":"14","author":"T Xia","year":"2025","unstructured":"Xia T, Yuan T, Chen LJ, Wang CL, Zhang EL, Liang BY, et\u00a0al. Autologous tumor-infiltrating lymphocyte infusion plus anti-programmed cell death protein 1 therapy to cure advanced hepatocellular carcinoma following palliative hepatectomy. Liver Cancer. 2025;14(4):497\u2013505.","journal-title":"Liver Cancer"},{"key":"979_CR172","doi-asserted-by":"crossref","unstructured":"He X, Liu Y, Dai T, Yang A, Shen J, Hui Z, et\u00a0al. Pathological study of the tumor microenvironment after neoadjuvant therapy in hepatocellular carcinoma: Difference of TACE combined with antiangiogenics and immunotherapy. Hepatol Commun. 2025;9(9).","DOI":"10.1097\/HC9.0000000000000787"},{"issue":"9","key":"979_CR173","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.7150\/ijbs.110406","volume":"21","author":"J You","year":"2025","unstructured":"You J, Yang X, Zhao J, Chen H, Tang Y, Ouyang D, et\u00a0al. Enhancing CAR-T cell metabolic fitness and memory phenotype for improved efficacy against hepatocellular carcinoma. Int J Biol Sci. 2025;21(9):4231\u201351.","journal-title":"Int J Biol Sci"},{"key":"979_CR174","doi-asserted-by":"crossref","unstructured":"Yu Y, Zou S, Fan J, Yang D, Liu N, Bai Z, et al. MMP14 is a safe target of CAR-T therapy against liver cancer and metastasis. J Transl Med. 2026;24(1).","DOI":"10.1186\/s12967-026-08036-x"},{"issue":"2","key":"979_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2026.201181","volume":"34","author":"R Liao","year":"2026","unstructured":"Liao R, Chan CKW, Cui Y, Li S, Ma R, Peng D, et\u00a0al. Chimeric antigen receptor T cell targeting CD44E variant in HCC holds therapeutic potential. Mol Ther Oncol. 2026;34(2):201181.","journal-title":"Mol Ther Oncol"},{"issue":"Pt 1","key":"979_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2026.150512","volume":"344","author":"HT Kannan","year":"2026","unstructured":"Kannan HT, Pan I. Next-generation therapies for hepatocellular carcinoma: CAR-T cell and anticancer peptide synergy. Int J Biol Macromol. 2026;344(Pt 1):150512.","journal-title":"Int J Biol Macromol"},{"key":"979_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2026.105304","volume":"222","author":"R Alsubki","year":"2026","unstructured":"Alsubki R. Engineering CAR-based cellular immunotherapy for hepatocellular carcinoma: Current barriers, innovative strategies, and future directions. Crit Rev Oncol Hematol. 2026;222:105304.","journal-title":"Crit Rev Oncol Hematol"},{"key":"979_CR178","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cytogfr.2025.12.006","volume":"87","author":"S Nabiyi","year":"2026","unstructured":"Nabiyi S, Heiat M, Rezaei E. Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: a comprehensive review. Cytokine Growth Factor Rev. 2026;87:89\u2013101.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"979_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102539","volume":"7","author":"T Liu","year":"2026","unstructured":"Liu T, Gao H, Xi Z, Yu T, Gu Y, Mai H, et\u00a0al. CAR-T triggers TAM reeducation and adaptive anti-tumor response via TREM2 deficiency or CD40 agonist. Cell Rep Med. 2026;7(1):102539.","journal-title":"Cell Rep Med"},{"key":"979_CR180","doi-asserted-by":"crossref","unstructured":"Zhu L, Wu M, Feng B, Zhang Y, Xu Y, Yu L. RNA helicase SKIV2L impedes tumor immunity by reprogramming arginine metabolism of hepatocellular carcinomas. J Immunother Cancer. 2026;14(4).","DOI":"10.1136\/jitc-2025-014192"},{"key":"979_CR181","doi-asserted-by":"crossref","unstructured":"Wang J, Cao W, Huang J, Zhou Y, Zheng R, Lou Y, et al. Tumor-associated CD19(+) macrophages induce immunosuppressive microenvironment in hepatocellular carcinoma. Nat Commun. 2026;17(1).","DOI":"10.1038\/s41467-026-69638-z"},{"issue":"1","key":"979_CR182","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12951-025-03512-w","volume":"23","author":"Z Yang","year":"2025","unstructured":"Yang Z, Cheng C, Li Z, Wang H, Zhang M, Xie E, et\u00a0al. Advancing liver cancer treatment with dual-targeting CAR-T therapy. J Nanobiotechnol. 2025;23(1):462.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"979_CR183","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12951-025-03424-9","volume":"23","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Gong Y, Li X, Zeng F, Liu B, Chen W, et\u00a0al. A spreadable self-gelling hemostatic powder sensitizes CAR-NK cell therapy to prevent hepatocellular carcinoma recurrence postresection. J Nanobiotechnol. 2025;23(1):353.","journal-title":"J Nanobiotechnol"},{"key":"979_CR184","doi-asserted-by":"crossref","unstructured":"Hong G, Han DK, Rhu J, Hong SK, Choi Y, Yi NJ, et al. Safety and therapeutic outcomes of adjuvant immunotherapy with autologous cytokine-induced killer cells for patients with hepatocellular carcinoma beyond Milan Criteria after liver transplantation. Transplantation. 2025.","DOI":"10.1097\/TP.0000000000005406"},{"key":"979_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114989","volume":"161","author":"J Lu","year":"2025","unstructured":"Lu J, Zhang T, Jiang C, Hu H, Fei Y, Yang Y, et\u00a0al. Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma. Int Immunopharmacol. 2025;161:114989.","journal-title":"Int Immunopharmacol"},{"issue":"Pt 3","key":"979_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.136459","volume":"281","author":"J Lin","year":"2024","unstructured":"Lin J, Huang J, Tan C, Wu S, Lu X, Pu J. LncRNA MEG3 suppresses hepatocellular carcinoma by stimulating macrophage M1 polarization and modulating immune system via inhibiting CSF-1 in vivo\/vitro studies. Int J Biol Macromol. 2024;281(Pt 3):136459.","journal-title":"Int J Biol Macromol"},{"key":"979_CR187","doi-asserted-by":"publisher","first-page":"1594585","DOI":"10.3389\/fonc.2025.1594585","volume":"15","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zheng X, Lin L, Chen M. Adverse events of pexidartinib for the treatment of TGCT: a real-world disproportionality analysis using FDA Adverse Event Reporting System database. Front Oncol. 2025;15:1594585.","journal-title":"Front Oncol"},{"issue":"2","key":"979_CR188","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tranon.2018.10.007","volume":"12","author":"K Vaeteewoottacharn","year":"2019","unstructured":"Vaeteewoottacharn K, Kariya R, Pothipan P, Fujikawa S, Pairojkul C, Waraasawapati S, et\u00a0al. Attenuation of CD47-SIRP\u03b1 signal in cholangiocarcinoma potentiates tumor-associated macrophage-mediated phagocytosis and suppresses intrahepatic metastasis. Transl Oncol. 2019;12(2):217\u201325.","journal-title":"Transl Oncol"},{"key":"979_CR189","doi-asserted-by":"crossref","unstructured":"Zhang Y, He B, Zou P, Wu M, Wei M, Xu C, et al. Targeted release of a bispecific fusion protein SIRP\u03b1\/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors. J Immunother Cancer. 2025;13(4).","DOI":"10.1136\/jitc-2024-010767"},{"issue":"3","key":"979_CR190","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00262-024-03931-y","volume":"74","author":"Z Xie","year":"2025","unstructured":"Xie Z, Shao J, Shen Z, Ye Z, Okada Y, Okuzaki D, et\u00a0al. HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells. Cancer Immunol Immunother. 2025;74(3):81.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"979_CR191","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.ymthe.2025.02.002","volume":"33","author":"TT Kwong","year":"2025","unstructured":"Kwong TT, Xiong Z, Zhang Y, Wu H, Cao J, Pak-Chun Wong P, et\u00a0al. Overcoming immunotherapy resistance in hepatocellular carcinoma by targeting myeloid IL-8\/CXCR2 signaling. Mol Ther. 2025;33(4):1659\u201373.","journal-title":"Mol Ther"},{"issue":"12","key":"979_CR192","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1002\/ijc.35390","volume":"156","author":"M Chivite-Lacaba","year":"2025","unstructured":"Chivite-Lacaba M, Justo I, Utrero-Rico A, Caso O, Gonz\u00e1lez-Cuadrado C, Del Rey MJ, et\u00a0al. Delineation of monocytic and early-stage myeloid-derived suppressor cells in the peripheral blood of patients with hepatocarcinoma. Int J Cancer. 2025;156(12):2416\u201328.","journal-title":"Int J Cancer"},{"issue":"12","key":"979_CR193","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1136\/gutjnl-2023-331117","volume":"73","author":"J Wen","year":"2024","unstructured":"Wen J, Zhang X, Wong CC, Zhang Y, Pan Y, Zhou Y, et\u00a0al. Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma. Gut. 2024;73(12):2023\u201336.","journal-title":"Gut"},{"issue":"9","key":"979_CR194","volume":"8","author":"C Wang","year":"2025","unstructured":"Wang C, Cai L, Xie Q, Zhang C, Chen X, Cui P, et\u00a0al. Identification of tumor antigens and immune subtypes in hepatocellular carcinoma from a multiomics perspective. Cancer Rep (Hoboken). 2025;8(9):e70300.","journal-title":"Cancer Rep (Hoboken)"},{"key":"979_CR195","doi-asserted-by":"publisher","first-page":"1633345","DOI":"10.3389\/fimmu.2025.1633345","volume":"16","author":"J Cheng","year":"2025","unstructured":"Cheng J, Wu S, Zhu C, Lin S, Liu F, Chen S, et\u00a0al. Bacterial outer membrane vesicles OMV-LL for delivery of neoantigen mRNA to induce anti-HCC therapy. Front Immunol. 2025;16:1633345.","journal-title":"Front Immunol"},{"key":"979_CR196","doi-asserted-by":"crossref","unstructured":"Sangsuwannukul T, Kendall B, Tonne J, Liseth O, Thompson J, Supimon K, et al. T cell exhaustion in poorly immunogenic HCC is partially rescued by checkpoint blockade but suppressed by oncolytic virotherapy. Mol Ther. 2025.","DOI":"10.1016\/j.ymthe.2025.08.046"},{"issue":"3","key":"979_CR197","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000533650","volume":"13","author":"GK Abou-Alfa","year":"2024","unstructured":"Abou-Alfa GK, Galle PR, Chao Y, Erinjeri J, Heo J, Borad MJ, et\u00a0al. PHOCUS: a phase 3, randomized, open-label study of sequential treatment with Pexa-Vec (JX-594) and sorafenib in patients with advanced hepatocellular carcinoma. Liver Cancer. 2024;13(3):248\u201364.","journal-title":"Liver Cancer"},{"issue":"7","key":"979_CR198","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.32604\/or.2025.061857","volume":"33","author":"Y Ye","year":"2025","unstructured":"Ye Y, Liu Y. Oncolytic virus therapy in hepatocellular carcinoma. Oncol Res. 2025;33(7):1593\u2013610.","journal-title":"Oncol Res"},{"key":"979_CR199","doi-asserted-by":"crossref","unstructured":"Wei K, Peng C, Ou Y, Wang P, Zhan C, Wei H, et al. Decoding hepatocellular carcinoma metastasis: molecular mechanisms, targeted therapies, and potential biomarkers. Curr Issues Mol Biol. 2025;47(4).","DOI":"10.3390\/cimb47040263"},{"key":"979_CR200","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.2147\/CMAR.S362594","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang L, Liu W. Roles of circRNAs in the Tumorigenesis and metastasis of HCC: a mini review. Cancer Manag Res. 2022;14:1847\u201356.","journal-title":"Cancer Manag Res"},{"key":"979_CR201","doi-asserted-by":"crossref","unstructured":"Wu S, Anand N, Guo Z, Li M, Santiago Figueroa M, Jung L, et al. Bridging immune evasion and vascular dynamics for novel therapeutic frontiers in hepatocellular carcinoma. Cancers (Basel). 2025;17(11).","DOI":"10.3390\/cancers17111860"},{"key":"979_CR202","doi-asserted-by":"crossref","unstructured":"Zheng J, He T, Chen J, Zhao J, Zhang S, Yang Z. Decoding the functional network of circular RNAs encoding proteins in hepatocellular carcinoma: from carcinogenesis to clinical transformation. J Adv Res. 2025.","DOI":"10.1016\/j.jare.2025.09.017"},{"key":"979_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156262","volume":"136","author":"Y Shao","year":"2025","unstructured":"Shao Y, Pu W, Su R, Wang Y, Yin S, Zhong H, et\u00a0al. Autocrine and paracrine LIF signals to collaborate sorafenib-resistance in hepatocellular carcinoma and effects of Kanglaite Injection. Phytomedicine. 2025;136:156262.","journal-title":"Phytomedicine"},{"issue":"8","key":"979_CR204","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.7150\/ijbs.91877","volume":"20","author":"Y Meng","year":"2024","unstructured":"Meng Y, Zhang M, Li X, Wang X, Dong Q, Zhang H, et\u00a0al. Myeloid cell-expressed MNDA enhances M2 polarization to facilitate the metastasis of hepatocellular carcinoma. Int J Biol Sci. 2024;20(8):2814\u201332.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"979_CR205","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.12998\/wjcc.v10.i11.3321","volume":"10","author":"M Yao","year":"2022","unstructured":"Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. World J Clin Cases. 2022;10(11):3321\u201333.","journal-title":"World J Clin Cases"},{"key":"979_CR206","doi-asserted-by":"publisher","first-page":"1164669","DOI":"10.3389\/fimmu.2023.1164669","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Mao M, Wang F, Zhang Y, Shi J, Chang L, et\u00a0al. Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma. Front Immunol. 2023;14:1164669.","journal-title":"Front Immunol"},{"key":"979_CR207","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jare.2023.08.011","volume":"61","author":"Y Gao","year":"2024","unstructured":"Gao Y, Chen S, Wang H, Wu C, An R, Li G, et\u00a0al. Liver metastases across cancer types sharing tumor environment immunotolerance can impede immune response therapy and immune monitoring. J Adv Res. 2024;61:151\u201364.","journal-title":"J Adv Res"},{"issue":"11","key":"979_CR208","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1158\/0008-5472.CAN-23-3106","volume":"84","author":"J Weng","year":"2024","unstructured":"Weng J, Wang Z, Hu Z, Xu W, Sun JL, Wang F, et\u00a0al. Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy. Cancer Res. 2024;84(11):1817\u201333.","journal-title":"Cancer Res"},{"issue":"1","key":"979_CR209","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/15384047.2022.2094666","volume":"23","author":"Y Li","year":"2022","unstructured":"Li Y, Wu J, Li E, Xiao Z, Lei J, Zhou F, et\u00a0al. TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma. Cancer Biol Ther. 2022;23(1):439\u201345.","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"979_CR210","first-page":"1356","volume":"18","author":"Q Yu","year":"2019","unstructured":"Yu Q, Cao S, Tang H, Li J, Guo W, Zhang S. Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma. Oncol Lett. 2019;18(2):1356\u201364.","journal-title":"Oncol Lett"},{"issue":"3","key":"979_CR211","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/abbs\/gmz005","volume":"51","author":"X Tao","year":"2019","unstructured":"Tao X, Zuo Q, Ruan H, Wang H, Jin H, Cheng Z, et\u00a0al. Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma. Acta Biochim Biophys Sin. 2019;51(3):263\u201376.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"11","key":"979_CR212","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.31557\/APJCP.2023.24.11.3851","volume":"24","author":"W Xing","year":"2023","unstructured":"Xing W, Li Y, Chen J, Hu Q, Liu P, Ge X, et\u00a0al. Association of APC expression with its promoter methylation status and the prognosis of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2023;24(11):3851\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"16","key":"979_CR213","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.3748\/wjg.v20.i16.4723","volume":"20","author":"XF Ji","year":"2014","unstructured":"Ji XF, Fan YC, Gao S, Yang Y, Zhang JJ, Wang K. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma. World J Gastroenterol. 2014;20(16):4723\u20139.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"979_CR214","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-025-07871-y","volume":"16","author":"H Chen","year":"2025","unstructured":"Chen H, Liao W, Jiang Y, Liao G, Gao X, Cen S, et\u00a0al. SORT1 promote the metastasis and invasion of hepatocellular carcinoma via p38\/\u03b2-catenin\/ZEB1 signaling pathway. Cell Death Dis. 2025;16(1):582.","journal-title":"Cell Death Dis"},{"issue":"76","key":"979_CR215","doi-asserted-by":"publisher","first-page":"34320","DOI":"10.18632\/oncotarget.26144","volume":"9","author":"Y Shigekawa","year":"2018","unstructured":"Shigekawa Y, Hayami S, Ueno M, Miyamoto A, Suzaki N, Kawai M, et\u00a0al. Overexpression of KDM5B\/JARID1B is associated with poor prognosis in hepatocellular carcinoma. Oncotarget. 2018;9(76):34320\u201335.","journal-title":"Oncotarget"},{"issue":"38","key":"979_CR216","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501373","volume":"12","author":"M Yang","year":"2025","unstructured":"Yang M, Cheng S, Gu H, Zhong S, Zhang D, He X, et\u00a0al. RPL6 interacts with HMGCS1 to stabilize HIF-1\u03b1 by promoting cholesterol production in hepatocellular carcinoma. Adv Sci (Weinh). 2025;12(38):e01373.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"979_CR217","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s13402-025-01085-2","volume":"48","author":"M Zheng","year":"2025","unstructured":"Zheng M, Liu L, Cui H, Zhao Y, Chen W, Bai S, et\u00a0al. Cancer-associated fibroblast-derived extracellular vesicles facilitate metastasis in hepatocellular carcinoma by delivering CTGF. Cell Oncol (Dordr). 2025;48(5):1413\u201332.","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"979_CR218","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i9.110527","volume":"17","author":"HP Tian","year":"2025","unstructured":"Tian HP, Wu TH, Zhang GJ, Li SJ. Transcription factor 3 enhances hepatocellular carcinoma metastasis by upregulating matrix metalloproteinase-11. World J Gastrointest Oncol. 2025;17(9):110527.","journal-title":"World J Gastrointest Oncol"},{"issue":"6","key":"979_CR219","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.21037\/jgo-2025-355","volume":"16","author":"Q Hu","year":"2025","unstructured":"Hu Q, Huang S, Li Z, Yu Y, Yu S, Wu D, et\u00a0al. Glutaryl-CoA dehydrogenase: a key biomarker linking lysine degradation to hepatocellular carcinoma metastasis and prognosis via NF-KB signaling pathway. J Gastrointest Oncol. 2025;16(6):2719\u201330.","journal-title":"J Gastrointest Oncol"},{"key":"979_CR220","doi-asserted-by":"crossref","unstructured":"Zhuang H, Dang Y, Sun L, Hong D, Zhai S, Shao X, et al. SAE1 emerges as a pan-cancer driver and key regulator of HCC metastasis. J Adv Res. 2025.","DOI":"10.1016\/j.jare.2025.06.028"},{"issue":"2","key":"979_CR221","doi-asserted-by":"publisher","first-page":"443","DOI":"10.32604\/or.2024.043948","volume":"33","author":"H Pang","year":"2025","unstructured":"Pang H, Wu F, Zhang YU, Zhang N, Wang C, Li Q, et\u00a0al. EMP2 promotes hepatocellular carcinoma proliferation and invasion by activating cellular autophagy. Oncol Res. 2025;33(2):443\u201364.","journal-title":"Oncol Res"},{"issue":"1","key":"979_CR222","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1038\/s41598-025-96548-9","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang J, Huang S, Liu X, Cai Y, Wang T, et\u00a0al. STAT3-mediated upregulation of TRIM6 promotes hepatocellular carcinoma invasion through the DDX58-Snail1 axis. Sci Rep. 2025;15(1):16284.","journal-title":"Sci Rep"},{"issue":"4","key":"979_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2024.100789","volume":"48","author":"CJ Liao","year":"2025","unstructured":"Liao CJ, Lin YH, Chien HT, Wang YW, Lin TK, Yeh CT, et\u00a0al. Cytidine deaminase enhances liver cancer invasion by modulating epithelial-mesenchymal transition via NF\u03baB signaling. Biomed J. 2025;48(4):100789.","journal-title":"Biomed J"},{"issue":"1","key":"979_CR224","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cas.16372","volume":"116","author":"L Hu","year":"2025","unstructured":"Hu L, Shi X, Yuan X, Liu D, Zheng D, Li Y, et\u00a0al. PPM1G-mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinoma. Cancer Sci. 2025;116(1):67\u201380.","journal-title":"Cancer Sci"},{"key":"979_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216598","volume":"584","author":"M Shan","year":"2024","unstructured":"Shan M, Liu D, Sun L, Yang M, He M, Zhang Y, et\u00a0al. KIAA1429 facilitates metastasis via m6A-YTHDC1-dependent RND3 down-regulation in hepatocellular carcinoma cells. Cancer Lett. 2024;584:216598.","journal-title":"Cancer Lett"},{"issue":"1","key":"979_CR226","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41389-023-00491-1","volume":"12","author":"S Guo","year":"2023","unstructured":"Guo S, Li F, Liang Y, Zheng Y, Mo Y, Zhao D, et\u00a0al. AIFM2 promotes hepatocellular carcinoma metastasis by enhancing mitochondrial biogenesis through activation of SIRT1\/PGC-1\u03b1 signaling. Oncogenesis. 2023;12(1):46.","journal-title":"Oncogenesis"},{"issue":"5","key":"979_CR227","first-page":"1094","volume":"11","author":"K Li","year":"2023","unstructured":"Li K, Niu Y, Li K, Zhong C, Qiu Z, Yuan Y, et\u00a0al. Dysregulation of PLOD2 promotes tumor metastasis and invasion in hepatocellular carcinoma. J Clin Transl Hepatol. 2023;11(5):1094\u2013105.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"979_CR228","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s12033-024-01125-6","volume":"67","author":"X Wang","year":"2025","unstructured":"Wang X, Feng JK, Mao FF, Hou YC, Zhang YQ, Liu LH, et\u00a0al. Prognostic and immunotherapeutic predictive value of CAD gene in hepatocellular carcinoma: integrated bioinformatics and experimental analysis. Mol Biotechnol. 2025;67(3):1240\u201355.","journal-title":"Mol Biotechnol"},{"issue":"12","key":"979_CR229","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.7150\/ijbs.85431","volume":"19","author":"X Hu","year":"2023","unstructured":"Hu X, Yuan S, Zhou S, Sun T, Wang C, Ying S, et\u00a0al. Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma. Int J Biol Sci. 2023;19(12):3694\u2013708.","journal-title":"Int J Biol Sci"},{"key":"979_CR230","doi-asserted-by":"crossref","unstructured":"You R, Yang Y, Yin G, Jiang H, Lu Y, Gui L, et al. CPEB2 suppresses hepatocellular carcinoma epithelial-mesenchymal transition and metastasis through regulating the HIF-1\u03b1\/miR-210-3p\/CPEB2 axis. Pharmaceutics. 2023;15(7).","DOI":"10.3390\/pharmaceutics15071887"},{"key":"979_CR231","doi-asserted-by":"publisher","first-page":"1138995","DOI":"10.3389\/fonc.2023.1138995","volume":"13","author":"G Li","year":"2023","unstructured":"Li G, Shen Q, Xu H, Zhou Y, Li C, Li Y, et\u00a0al. SAA1 identified as a potential prediction biomarker for metastasis of hepatocellular carcinoma via multi-omics approaches. Front Oncol. 2023;13:1138995.","journal-title":"Front Oncol"},{"issue":"1","key":"979_CR232","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","volume":"79","author":"M Xie","year":"2023","unstructured":"Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, et\u00a0al. FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. J Hepatol. 2023;79(1):109\u201325.","journal-title":"J Hepatol"},{"key":"979_CR233","doi-asserted-by":"crossref","unstructured":"Cigliano A, Liao W, Deiana GA, Rizzo D, Chen X, Calvisi DF. Preclinical models of hepatocellular carcinoma: current utility, limitations, and challenges. Biomedicines. 2024;12(7).","DOI":"10.3390\/biomedicines12071624"},{"key":"979_CR234","doi-asserted-by":"crossref","unstructured":"Tsuge M. Are humanized mouse models useful for basic research of hepatocarcinogenesis through chronic hepatitis B virus infection? Viruses. 2021;13(10).","DOI":"10.3390\/v13101920"},{"issue":"12","key":"979_CR235","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/1750743X.2025.2549675","volume":"17","author":"DP Pallotta","year":"2025","unstructured":"Pallotta DP, Stefanini B, Pratelli A, Papayannidis C, Bertuzzi C, Boe M, et\u00a0al. Pure red cell aplasia due to parvovirus B19 infection and atezolizumab: case report and literature review. Immunotherapy. 2025;17(12):871\u20137.","journal-title":"Immunotherapy"},{"issue":"5","key":"979_CR236","doi-asserted-by":"publisher","first-page":"651","DOI":"10.5009\/gnl250187","volume":"19","author":"M Mino","year":"2025","unstructured":"Mino M, Kakazu E, Kanto T. Precision strategy for hepatocellular carcinoma surveillance after hepatitis C cure: debates across guidelines. Gut Liver. 2025;19(5):651\u201364.","journal-title":"Gut Liver"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-026-00979-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00979-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-026-00979-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:02:55Z","timestamp":1790647375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11658-026-00979-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":236,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1186\/s11658-026-00979-9","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"153"}}